Dr Zachary Jerrell, PT in Fort Stewart, GU - Physical Therapist

Dr Zachary Jerrell, PT is a Physical Therapist based in Fort Stewart, Guam. Dr Zachary Jerrell is licensed to practice in Georgia (license number PT010383) and his current practice location is 1061 Harmon Ave, Fort Stewart, Guam. He can be reached at his office (for appointments etc.) via phone at (912) 435-6965.

NPI number for Dr Zachary Jerrell is 1073891255 and his current mailing address is 1061 Harmon Ave, Fort Stewart, Guam. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1073891255.

Contact Information

	Dr Zachary Jerrell, PT
	1061 Harmon Ave, Fort Stewart, GU 31314-5674
	(912) 435-6965
	Not Available

Healthcare Provider's Profile

Full Name	Dr Zachary Jerrell
Gender	Male
Speciality	Physical Therapist
Location	1061 Harmon Ave, Fort Stewart, Guam
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1073891255
Provider Enumeration Date: 07/22/2011
Last Update Date: 02/22/2024

Medical Identifiers

Medical identifiers for Dr Zachary Jerrell such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073891255	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	PT010383 (Georgia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Zachary Jerrell is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Zachary Jerrell, PT 1061 Harmon Ave, Fort Stewart, GU 31314-5674 Ph: (912) 435-6965	Dr Zachary Jerrell, PT 1061 Harmon Ave, Fort Stewart, GU 31314-5674 Ph: (912) 435-6965

News Archive

NGM Biopharmaceuticals announces completion of $50 million Series C financing

NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.

Lupin introduces new InspiraChamber VHC under strategic licensing agreement with InspiRX

Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the all new InspiraChamber Anti-Static Valved Holding Chamber (VHC) under a strategic licensing agreement with the New Jersey based respiratory research and development company InspiRX Inc.

Researchers develop antibody with potential therapeutic effects against multiple sclerosis

Inserm Unit U919, directed by Prof. Denis Vivien has developed an antibody with potential therapeutic effects against multiple sclerosis.

Advion introduces high performance liquid chromatography to complement its CMS

Advion, Inc., a leading systems and consumables developer for the life sciences industry, introduces an affordable high performance liquid chromatography system to complement its line of expression compact mass spectrometers (CMS). Introduced in 2012, the CMS has been met with glowing reviews from the global synthetic organic chemistry market. With hundreds of CMS purchased and installed, this latest introduction offers a complete solution for those needing separation capabilities at an affordable price.

Dr Zachary Jerrell, PT - Physical Therapist in Fort Stewart, GU